As of: August 29, 2018
SYMBOL | DSCIX |
INCEPTION DATE | 11/2/15 |
BENCHMARK | Russell 2000 Index |
TOTAL FUND AUM | $9.86 MM |
TOTAL FIRM AUM | $6.6 BN |
MIN. INVESTMENT | $5,000 |
NET EXPENSE RATIO | 0.95% |
GROSS EXPENSE RATIO | 1.88% |
NUMBER OF HOLDINGS | 60 – 65 |
TARGET CASH POSITION | 0 – 1% |
INDIVIDUAL SECURITY LIMIT | < 4% |
SECTOR LIMITS | SECTOR NEUTRAL |
Data source: Morningstar Direct; The Adviser has contractually agreed to waive its management fee and/or reimburse certain operating expenses through 2/28/2021, so that Total Annual Operating Expenses does not exceed 0.95% for the Fund. Time period for statistical calculations is from fund inception to 10/31/20.
BLUEPRINT MEDICINES CORP. | 2.44% |
OMNICELL, INC. | 2.22% |
DECKERS OUTDOOR CORPORATION | 2.16% |
TOPBUILD CORP. | 2.15% |
BOOT BARN HOLDINGS, INC. | 2.07% |
EMERGENT BIOSOLUTIONS, INC. | 2.04% |
ENSIGN GROUP, INC. | 2.02% |
COHU, INC. | 2.01% |
HORIZON THERAPEUTICS PLC | 1.99% |
E.L.F. BEAUTY, INC. | 1.90% |